$KLRS 4 SEC Filings

Filed On	Filing
28 Aug 2026	Form 4: Vandekop Amy O'Leary, VP, Corporate Controller Granted 10,000 Stock Option (Right to Buy)
03 Aug 2026	Form 4: Keating Laurie, Director Granted 18,000 Stock Option (Right to Buy)
20 Jul 2026	Form 4: Bayko Liisa Ann, Chief Financial Officer Granted 220,000 Stock Option (Right to Buy)
04 Jun 2026	Form 4: Ferrara Napoleone, Director Granted 9,000 Stock Option (Right to Buy)
04 Jun 2026	Form 4: Jovan-Embiricos Morana, Director Granted 9,000 Stock Option (Right to Buy)
04 Jun 2026	Form 4: Hallal David, Director Granted 9,000 Stock Option (Right to Buy)
04 Jun 2026	Form 4: Akkaraju Srinivas, Director Granted 9,000 Stock Option (Right to Buy)
04 Jun 2026	Form 4: Adamis Anthony P, Director Granted 9,000 Stock Option (Right to Buy)
04 Jun 2026	Form 4: Dybbs Michael, Director Granted 9,000 Stock Option (Right to Buy)
04 Jun 2026	Form 4: Patterson Leone D, Director Granted 9,000 Stock Option (Right to Buy)
22 May 2026	Form 4: Akkaraju Srinivas, Director and 4 others Bought 244,300 shares ($1.18M) · Disposed of 66,906 shares (Other Transaction) · Acquired 19,408 shares (Other Transaction)
23 Mar 2026	Form 4: Hagen Brett R, Chief Accounting Officer Granted 60,800 Stock Option (Right to Buy) · Sold 1,915 shares ($12.9K)
20 Mar 2026	Form 4: Feinsod Matthew, Chief Medical Officer Granted 135,000 Stock Option (Right to Buy)
20 Mar 2026	Form 4: Oxtoby Andrew, Director Granted 222,000 Stock Option (Right to Buy)
20 Mar 2026	Form 4: Gall Matthew, Chief Financial Officer Granted 95,000 Stock Option (Right to Buy)
17 Feb 2026	Form 4: Akkaraju Srinivas, Director and 4 others Bought 479,847 shares ($5M)
22 Dec 2025	Form 4: Akkaraju Srinivas, Director and 2 others Received 1,500,000 shares as a grant or award ($15M)
03 Nov 2025	Form 4: Gall Matthew, Chief Financial Officer Granted 235,000 Stock Option (Right to Buy)
11 Apr 2025	Form 4: Hagen Brett R, Chief Accounting Officer Granted 50,262 Stock Option (Right to Buy)
11 Apr 2025	Form 4: Akkaraju Srinivas, Director Granted 18,000 Stock Option (Right to Buy)

Comments